nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Randomized Comparison of Cisplatin and Oral Vinorelbine as Radiosensitizers in Aged or Comorbid Locally Advanced Cervical Cancer Patients
|
Coronel, Jaime Alberto |
|
|
23 |
5 |
p. 884-889 |
artikel |
2 |
CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer
|
Chen, Xiaoxiang |
|
|
23 |
5 |
p. 815-822 |
artikel |
3 |
Clinical Significance of hTERC Gene Detection in Exfoliated Cervical Epithelial Cells for Cervical Lesions
|
Zheng, Xiuhui |
|
|
23 |
5 |
p. 785-790 |
artikel |
4 |
Comparison of Current Staging Systems and a Novel Staging System for Uterine Leiomyosarcoma
|
Giuntoli, Robert L. |
|
|
23 |
5 |
p. 869-876 |
artikel |
5 |
Completion Surgery After Intensity-Modulated Arc Therapy in the Treatment of Locally Advanced Cervical Cancer: Feasibility, Surgical Outcome, and Oncologic Results
|
Tummers, Philippe |
|
|
23 |
5 |
p. 877-883 |
artikel |
6 |
Constitutive Activation of Nuclear Factor κB Contributes to Cystic Fibrosis Transmembrane Conductance Regulator Expression and Promotes Human Cervical Cancer Progression and Poor Prognosis
|
Wu, Zhao |
|
|
23 |
5 |
p. 906-915 |
artikel |
7 |
Cost-Effectiveness of BRCA1 and BRCA2 Mutation Testing to Target PARP Inhibitor Use in Platinum-Sensitive Recurrent Ovarian Cancer
|
Secord, Angeles Alvarez |
|
|
23 |
5 |
p. 846-852 |
artikel |
8 |
Curcumin Induces Cross-Regulation Between Autophagy and Apoptosis in Uterine Leiomyosarcoma Cells
|
Bin, Li |
|
|
23 |
5 |
p. 803-808 |
artikel |
9 |
Editorial
|
Beller, Uziel |
|
|
23 |
5 |
p. 781 |
artikel |
10 |
Erratum
|
|
|
|
23 |
5 |
p. 978 |
artikel |
11 |
Erythropoiesis-Stimulating Agents in Ovarian Cancer Patients Receiving Chemotherapy
|
Marchetti, Claudia |
|
|
23 |
5 |
p. 783-784 |
artikel |
12 |
Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer
|
Klaus, Pietzner |
|
|
23 |
5 |
p. 797-802 |
artikel |
13 |
Feasibility of Adjuvant Chemotherapy After Pelvic Exenteration for Gynecologic Malignancies
|
Andikyan, Vaagn |
|
|
23 |
5 |
p. 923-928 |
artikel |
14 |
Fibroblast Growth Factor Receptor 2 Expression May Be Involved In Transformation of Ovarian Endometrioma to Clear Cell Carcinoma of the Ovary
|
Taniguchi, Fuminori |
|
|
23 |
5 |
p. 791-796 |
artikel |
15 |
Induction of Antitumor Immunity Against Cervical Cancer by Protein HPV-16 E7 in Fusion With Ricin B Chain in Tumor-Bearing Mice
|
Mohammad, Sadraeian |
|
|
23 |
5 |
p. 809-814 |
artikel |
16 |
Interobserver Variability of the International Federation of Gynecology and Obstetrics Staging in Cervical Cancer
|
Tummers, Philippe |
|
|
23 |
5 |
p. 890-894 |
artikel |
17 |
Knowledge, Attitudes, Practices, and Perceived Risk of Cervical Cancer Among Kenyan Women
|
Sudenga, Staci L. |
|
|
23 |
5 |
p. 895-899 |
artikel |
18 |
Lymphocele Prevention After Pelvic Laparoscopic Lymphadenectomy by a Collagen Patch Coated With Human Coagulation Factors
|
Tinelli, Andrea |
|
|
23 |
5 |
p. 956-963 |
artikel |
19 |
Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging
|
Kim, Christine H. |
|
|
23 |
5 |
p. 964-970 |
artikel |
20 |
Performance Status and Symptom Scores of Women With Gynecologic Cancer at the End of Life
|
Spoozak, Lori |
|
|
23 |
5 |
p. 971-978 |
artikel |
21 |
Pooled Analysis of the Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients With Ovarian Cancer
|
Fehm, Tanja |
|
|
23 |
5 |
p. 839-845 |
artikel |
22 |
Should Bevacizumab Be Continued After Progression on Bevacizumab in Recurrent Ovarian Cancer?
|
Backes, Floor J. |
|
|
23 |
5 |
p. 833-838 |
artikel |
23 |
Simple Vaginal Trachelectomy in Early-Stage Low-Risk Cervical Cancer
|
Plante, Marie |
|
|
23 |
5 |
p. 916-922 |
artikel |
24 |
Survival Analysis of Endometrial Cancer Patients With Positive Lymph Nodes
|
Brown, Aaron P. |
|
|
23 |
5 |
p. 861-868 |
artikel |
25 |
The Role of Minimally Invasive Surgery in Ovarian Cancer
|
Nezhat, Farr R. |
|
|
23 |
5 |
p. 782-783 |
artikel |
26 |
The Use of Laparostomy in Patients With Gynecologic Cancer
|
Kaushik, Sonali |
|
|
23 |
5 |
p. 951-955 |
artikel |
27 |
Treatment of Advanced or Recurrent Endometrial Carcinoma With Doxorubicin in Patients Progressing After Paclitaxel/Carboplatin
|
Makker, Vicky |
|
|
23 |
5 |
p. 929-934 |
artikel |
28 |
Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review
|
Kim, Kun |
|
|
23 |
5 |
p. 823-832 |
artikel |
29 |
Two-Port Access Laparoscopic Surgery in Gynecologic Oncology
|
Lee, Maria |
|
|
23 |
5 |
p. 935-942 |
artikel |
30 |
Vaginal Vault Dehiscence After Robotic Hysterectomy for Gynecologic Cancers
|
Drudi, Laura |
|
|
23 |
5 |
p. 943-950 |
artikel |
31 |
Villoglandular Papillary Adenocarcinoma of the Cervix
|
Lataifeh, Isam M. |
|
|
23 |
5 |
p. 900-905 |
artikel |
32 |
Women 50 Years Or Younger With Endometrial Cancer: The Argument for Universal Mismatch Repair Screening and Potential for Targeted Therapeutics
|
Ring, Kari L. |
|
|
23 |
5 |
p. 853-860 |
artikel |